| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_423998b6e08b1afa15e32d50717fc68b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
1983-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fd660759ccf8f1f182dc635b4b6d83e |
| publicationDate |
1984-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0109234-A1 |
| titleOfInvention |
Compositions comprising interferon and their therapeutic use |
| abstract |
57 The combination of 9-[[2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl]guanine, or a pharmaceutically acceptable salt thereof, and interferon can show synergy in activity against herpesvirus infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4782065-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4800081-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177910-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0181455-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9915026-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177910-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5093116-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4849412-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5145677-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8707508-A1 |
| priorityDate |
1982-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |